Our Services

We offer consultancy and operational management services to bridge the gap between therapeutic lead identification to the clinical stage and to the patient PoC.

Population PK modeling appears to be a powerful tool to support clinical development, responding to clinical and financial constraints, by allowing the establishment of clinical management strategies at critical points in the process.

Our pharmacokineticists provide precise analysis of data, whatever the purpose of your pharmacokinetic (PK) studies. We cover all PK analysis requirements.

Physiologically Based PharmacoKinetic (PBPK) modeling is a mechanistic approach to predict the absorption, distribution, metabolism and excretion of drugs.

As the pharmaceutical industry continues to advance, the understanding and management of Drug-Drug Interactions (DDI) are becoming increasingly crucial.

Achieve compliance and take advantage of the CDISC standards for pharmacokinetic modeling!

Modeling and Simulation (M&S) is a combination of tools to optimize your clinical development. These techniques are used to make the most of the clinical studies data and make the best predictions and simulations.

Inadequate dose selection for confirmatory trials is currently still one of the most challenging issues in drug development, as illustrated by high rates of late‐stage attritions in clinical development.